ArticleExperimental and therapeutic medicine2017

miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.

Shu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.